NO951212D0 - Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus - Google Patents
Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirusInfo
- Publication number
- NO951212D0 NO951212D0 NO951212A NO951212A NO951212D0 NO 951212 D0 NO951212 D0 NO 951212D0 NO 951212 A NO951212 A NO 951212A NO 951212 A NO951212 A NO 951212A NO 951212 D0 NO951212 D0 NO 951212D0
- Authority
- NO
- Norway
- Prior art keywords
- monoclonal antibodies
- immunodeficiency virus
- human
- antibodies against
- neutralizing monoclonal
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title abstract 3
- 230000003472 neutralizing effect Effects 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95414892A | 1992-09-30 | 1992-09-30 | |
PCT/US1993/009328 WO1994007922A1 (en) | 1992-09-30 | 1993-09-30 | Human neutralizing monoclonal antibodies to human immunodeficiency virus |
Publications (2)
Publication Number | Publication Date |
---|---|
NO951212D0 true NO951212D0 (no) | 1995-03-29 |
NO951212L NO951212L (no) | 1995-05-29 |
Family
ID=25495000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO951212A NO951212L (no) | 1992-09-30 | 1995-03-29 | Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0675904B1 (no) |
JP (1) | JPH08502260A (no) |
AT (1) | ATE233814T1 (no) |
AU (1) | AU681360B2 (no) |
CA (1) | CA2145757A1 (no) |
DE (1) | DE69332744T2 (no) |
ES (1) | ES2194015T3 (no) |
FI (1) | FI951488A (no) |
NO (1) | NO951212L (no) |
WO (1) | WO1994007922A1 (no) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1231268B1 (en) | 1994-01-31 | 2005-07-27 | Trustees Of Boston University | Polyclonal antibody libraries |
US6428790B1 (en) | 1995-04-27 | 2002-08-06 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
US6987096B1 (en) | 1995-04-27 | 2006-01-17 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof |
US5843882A (en) | 1995-04-27 | 1998-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral proteins and peptides |
US6780847B2 (en) | 1995-04-27 | 2004-08-24 | The United States Of America As Represented By The Department Of Health And Human Services | Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
US7048935B2 (en) | 1995-04-27 | 2006-05-23 | The United States Of America As Represented By The Department Of Health And Human Services | Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
US6193982B1 (en) | 1995-04-27 | 2001-02-27 | The United States Of America As Represented By The Department Of Health & Human Services | Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
US6255455B1 (en) | 1996-10-11 | 2001-07-03 | The Trustees Of The University Of Pennsylvania | Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof |
DE19809785C2 (de) * | 1998-03-08 | 2000-02-10 | Wolfgang Bergter | Radioimmunpharmakon zur Behandlung der HIV-1-Infektion |
JP2002519334A (ja) * | 1998-06-29 | 2002-07-02 | ベルクター,ヴォルフガンク | αエミッタとβエミッタとを主成分とする抗ウイルスおよび抗レトロウイルス放射免疫薬剤 |
AU2487300A (en) | 1998-12-31 | 2000-07-31 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
GB9908533D0 (en) | 1999-04-14 | 1999-06-09 | Novartis Ag | Organic compounds |
WO2001079481A2 (en) | 2000-04-17 | 2001-10-25 | Dyax Corp. | Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
EP1360288B1 (en) | 2000-12-18 | 2011-02-16 | Dyax Corp. | Focused libraries of genetic packages |
CA2441287C (en) | 2001-03-22 | 2014-06-10 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
WO2003004620A2 (en) | 2001-07-05 | 2003-01-16 | Chiron, Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
AU2002337885B1 (en) | 2001-10-16 | 2003-04-28 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Broadly cross-reactive neutralizing antibodies against human ummunodeficiency virus selected by Env-CD4-co-receptor complexes |
WO2003092630A2 (en) | 2002-05-06 | 2003-11-13 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
EP1504034B1 (en) | 2002-05-06 | 2012-12-12 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
US20070292390A1 (en) * | 2004-10-29 | 2007-12-20 | Dimitrov Dimiter S | Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies |
US8691730B2 (en) | 2007-09-14 | 2014-04-08 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
US9873957B2 (en) | 2008-03-13 | 2018-01-23 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR3 designs |
CA2968164C (en) | 2008-04-24 | 2019-08-20 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs |
EP2593594B1 (en) | 2010-07-16 | 2017-09-27 | Adimab, LLC | Antibody libraries |
EP2492279A1 (en) | 2011-02-25 | 2012-08-29 | Laboratorios Del. Dr. Esteve, S.A. | Rapid immunogen selection method using lentiviral display |
EP2698377A1 (en) | 2012-08-17 | 2014-02-19 | Laboratorios Del. Dr. Esteve, S.A. | Enhanced rapid immunogen selection method for HIV gp120 variants |
TW202417468A (zh) * | 2017-11-17 | 2024-05-01 | 美商格里佛診斷方法股份有限公司 | 重組多肽、包含其之免疫分析試劑、寡聚多肽、組合物、使用其之裝置、方法和用途、包含編碼其之核苷酸序列的核酸及包含該核酸的經分離細胞 |
CN118459598A (zh) | 2019-12-27 | 2024-08-09 | 凯奥目生物科学株式会社 | 抗cdcp1抗体 |
WO2022049867A1 (ja) | 2020-09-02 | 2022-03-10 | 国立大学法人東京大学 | がん免疫微小環境の調節物質およびそれによる予防・診断・治療的利用 |
CN112521492B (zh) * | 2020-12-18 | 2022-05-20 | 杭州贤至生物科技有限公司 | 乙肝表面抗原单克隆抗体的制备 |
-
1993
- 1993-09-30 JP JP6509318A patent/JPH08502260A/ja not_active Ceased
- 1993-09-30 AU AU53501/94A patent/AU681360B2/en not_active Ceased
- 1993-09-30 DE DE69332744T patent/DE69332744T2/de not_active Expired - Fee Related
- 1993-09-30 EP EP93923749A patent/EP0675904B1/en not_active Expired - Lifetime
- 1993-09-30 CA CA002145757A patent/CA2145757A1/en not_active Abandoned
- 1993-09-30 WO PCT/US1993/009328 patent/WO1994007922A1/en active IP Right Grant
- 1993-09-30 ES ES93923749T patent/ES2194015T3/es not_active Expired - Lifetime
- 1993-09-30 AT AT93923749T patent/ATE233814T1/de not_active IP Right Cessation
-
1995
- 1995-03-29 NO NO951212A patent/NO951212L/no unknown
- 1995-03-29 FI FI951488A patent/FI951488A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU681360B2 (en) | 1997-08-28 |
EP0675904A1 (en) | 1995-10-11 |
EP0675904B1 (en) | 2003-03-05 |
CA2145757A1 (en) | 1994-04-14 |
AU5350194A (en) | 1994-04-26 |
ATE233814T1 (de) | 2003-03-15 |
JPH08502260A (ja) | 1996-03-12 |
NO951212L (no) | 1995-05-29 |
FI951488A0 (fi) | 1995-03-29 |
WO1994007922A1 (en) | 1994-04-14 |
DE69332744T2 (de) | 2004-01-15 |
EP0675904A4 (en) | 1996-08-21 |
FI951488A (fi) | 1995-05-23 |
DE69332744D1 (de) | 2003-04-10 |
ES2194015T3 (es) | 2003-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO951212D0 (no) | Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus | |
NO970221L (no) | Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus | |
ATE405679T1 (de) | Synthetische humane neutralisierende monoklonale antikörper gegen hiv | |
NO950881D0 (no) | Nöytraliserende monoklonale menneske-antistoffer mot andedretts-syncytial-virus | |
HUP9802212A2 (hu) | Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok | |
DK1212422T3 (da) | Humane CTLA-4-antistoffer og anvendelserne deraf | |
ES2067866T3 (es) | Reactivos inmunologicos que reaccionan con un epitopo constante del virus inmunodeficiente humano del tipo i (vih-1)gp120 y metodos de utilizacion. | |
TW200517121A (en) | Immunogen | |
BRPI9709524B8 (pt) | processo para a produção de um anticorpo para células t que expressam cd4 | |
FI873410A0 (fi) | Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita | |
MX9301858A (es) | Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv. | |
SE9201281D0 (sv) | New human monoclonal antibodies, and a method for preparation thereof | |
AU4959193A (en) | High affinity, strongly neutralizing monoclonal antibodies against the CD-4 binding site of GP120 of human immunodeficiency virus | |
ATE132502T1 (de) | Peptide, die epitope auf r-ifn-beta repräsentieren, antikörper dagegen, und ihre anwendung | |
ES544306A0 (es) | Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer. | |
ES2061655T3 (es) | Un procedimiento para cultivar un hibridoma humano/humano productor de anticuerpos monoclonales humanos. | |
ATE128733T1 (de) | Monoklonale antikörper gegen hiv gp120. | |
DE59207362D1 (de) | Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
ES2060162T3 (es) | Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina. | |
ES2051870T3 (es) | Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t. | |
IT7919222A0 (it) | Procedimento per produrre anticorpi umani. | |
FI850484L (fi) | Diagnostiskt foerfarande, vid vilket man utnyttjar en ny monoklonal antikropp specifik mot maenniskans t-cellers antigen. |